Implications in dental treatment during the use of antiresorptive drugs - a literature review
DOI:
https://doi.org/10.12775/JEHS.2024.69.55356Keywords
antiresorptives, bisphosphonates, osteonecrosis of the jaw, MRONJAbstract
Introduction: Antiresorptive drugs such as bisphosphonates and denosumab are crucial for treating osteoporosis, metastatic bone disease, and hypercalcemia by inhibiting osteoclast function. They can lead to medication-related osteonecrosis of the jaw (MRONJ) following invasive dental procedures, requiring careful management to mitigate potential adverse effects.
Purpose of work: Synthesis of knowledge about the impact of taking antiresorptive drugs on aspects of dental treatment.
Materials and methods: Materials used in this study were found in the PubMed and Google Scholar database, using the following key words “antiresorptives”, “bisphosphonates”, “dental treatment”, “osteonecrosis of the jaw”
Summary: Antiresorptive drugs like bisphosphonates and denosumab are essential for managing osteoporosis and other bone diseases but pose challenges in dental care, notably with risks such as medication-related osteonecrosis of the jaw (MRONJ). These medications influence treatment strategies across orthodontics, implantology, periodontal therapy, and endodontics, necessitating careful management to balance therapeutic benefits with potential dental complications.
References
Granić M. Antiresorptive Treatment in Dentistry. Medicus [Internet]. 2022;31(2 Osteoporoza):253–9. [cited 2024 May 25] Available from: https://hrcak.srce.hr/291568
Bartl R, von Tresckow E. Pharmacological Aspects of Antiresorptive Drugs: Bisphosphonates and Denosumab. In: Otto S, editor. Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents [Internet]. Berlin, Heidelberg: Springer; 2015 [cited 2024 May 24]. p. 1–15. Available from: https://doi.org/10.1007/978-3-662-43733-9_1
Ganesan K, Goyal A, Roane D. Bisphosphonate. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 May 25]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470248/
Song M. Dental care for patients taking antiresorptive drugs: a literature review. Restor Dent Endod [Internet]. 2019 Nov 1 [cited 2024 May 31];44(4):e42. Available from: https://doi.org/10.5395/rde.2019.44.e42
Dahiya N, Khadka A, Sharma AK, Gupta AK, Singh N, Brashier DBS. Denosumab: A bone antiresorptive drug. Medical Journal Armed Forces India [Internet]. 2015 Jan 1 [cited 2024 May 26];71(1):71–5. Available from: https://doi.org/10.1016/j.mjafi.2014.02.001
Kendler DL, Cosman F, Stad RK, Ferrari S. Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review. Adv Ther [Internet]. 2022 Jan 1 [cited 2024 Jun 1];39(1):58–74. Available from: https://doi.org/10.1007/s12325-021-01936-y
Lim SY. Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk. Womens Health (Lond Engl) [Internet]. 2022 Jan 1 [cited 2024 May 26]. Available from: https://doi.org/10.1177/17455057221125577
Miller SA, St. Onge EL, Whalen KL. Romosozumab: A Novel Agent in the Treatment for Postmenopausal Osteoporosis. Journal of Pharmacy Technology [Internet]. 2021 Feb 1 [cited 2024 Jun 1];37(1):45–52. Available from: https://doi.org/10.1177/8755122520967632
Sulaiman N, Fadhul F, Chrcanovic BR. Bisphosphonates and Dental Implants: A Systematic Review and Meta-Analysis. Materials (Basel). [Internet] 2023 Sep 5;16(18):6078. Available from: https://doi.org/10.3390/ma16186078
Eguia A, Bagan L, Cardona F. Review and update on drugs related to the development of osteonecrosis of the jaw. Med Oral Patol Oral Cir Bucal [Internet]. 2020 Jan [cited 2024 May 31];25(1):e71–83. Available from: http://dx.doi.org/doi:10.4317/medoral.23191
Woolley J, Akintola O, Yates J, Calasans-Maia MD, Calasans-Maia J de A, Kocherhina I, et al. The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review. Heliyon [Internet]. 2021 Jan 1 [cited 2024 May 31];7(1). Available from: https://doi.org/10.1016/j.heliyon.2021.e05914
Sivolella S, Lumachi F, Stellini E, Favero L. Denosumab and Anti-angiogenetic Drug-related Osteonecrosis of the Jaw: An Uncommon but Potentially Severe Disease. Anticancer Research [Internet]. 2013 May 1 [cited 2024 Jun 2];33(5):1793–7. Available from: https://ar.iiarjournals.org/content/33/5/1793
Schwartz HC. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update and CTX. Journal of Oral and Maxillofacial Surgery [Internet]. 2015 Mar 1 [cited 2024 Jun 2];73(3):377. Available from: https://doi.org/10.1016/j.joms.2014.10.035
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update. Journal of Oral and Maxillofacial Surgery [Internet]. 2014 Oct 1 [cited 2024 Jun 5];72(10):1938–56. Available from: https://doi.org/10.1016/j.joms.2014.04.031
Lee ES, Tsai MC, Lee JX, Wong C, Cheng YN, Liu AC, et al. Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws. Cancers [Internet]. 2023 Jan [cited 2024 May 31];15(22):5366. Available from: https://doi.org/10.3390/cancers15225366
Nogueira D, Caldas IM, Dinis-Oliveira RJ. Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects. Archives of Oral Biology [Internet]. 2023 Nov 1 [cited 2024 May 31];155:105792. Available from: https://doi.org/10.1016/j.archoralbio.2023.105792
Tetradis S, Allen MR, Ruggiero SL. Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview. JBMR Plus [Internet]. 2023 Jun 22 [cited 2024 Jun 5];7(8):e10785. Available from: https://doi.org/10.1002%2Fjbm4.10785
Thomas JG, Ouanounou A. Medication-related osteonecrosis of the jaw: a narrative review of risk factors, diagnosis, and management. Frontiers of Oral and Maxillofacial Medicine [Internet]. 2023 Dec 30 [cited 2024 Jun 5];5(0). Available from: https://dx.doi.org/10.21037/fomm-21-106
Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. Journal of Oral and Maxillofacial Surgery [Internet]. 2022 May 1 [cited 2024 Jun 2];80(5):920–43. Available from: https://doi.org/10.1016/j.joms.2022.02.008
AlRowis R, Aldawood A, AlOtaibi M, Alnasser E, AlSaif I, Aljaber A, et al. Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies. The Saudi Dental Journal [Internet]. 2022 Mar 1 [cited 2024 Jun 5];34(3):202–10. Available from: https://doi.org/10.1016/j.sdentj.2022.01.003
Gao S yong, Lin R bang, Huang S hui, Liang Y jie, Li X, Zhang S en, et al. PDGF-BB exhibited therapeutic effects on rat model of bisphosphonate-related osteonecrosis of the jaw by enhancing angiogenesis and osteogenesis. Bone [Internet]. 2021 Mar 1 [cited 2024 Jun 2];144:115117. Available from: https://doi.org/10.1016/j.bone.2019.115117
He L, Sun X, Liu Z, Qiu Y, Niu Y. Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int J Oral Sci [Internet]. 2020 Oct 21 [cited 2024 Jun 5];12(1):1–11. Available from: https://doi.org/10.1038/s41368-020-00093-2
Singh M, Gonegandla GS. Bisphosphonate-Induced Osteonecrosis of the Jaws (BIONJ). J Maxillofac Oral Surg [Internet]. 2020 Jun [cited 2024 May 31];19(2):162–7. Available from: https://doi.org/10.1007/s12663-019-01211-2
Boston B, Ipe D, Capitanescu B, Gresita A, Hamlet S, Love R, et al. Medication-related osteonecrosis of the jaw: A disease of significant importance for older patients. Journal of the American Geriatrics Society [Internet]. 2023 [cited 2024 May 31];71(8):2640–52. Available from: https://doi.org/10.1111/jgs.18414
Bansal H. Medication-related osteonecrosis of the jaw: An update. Natl J Maxillofac Surg [Internet]. 2022 [cited 2024 Jun 8];13(1):5–10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326203/
Migliorati CA. Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ). Front Oral Health [Internet]. 2022 Apr 26 [cited 2024 May 31];3:866871. Available from: https://doi.org/10.3389/froh.2022.866871
Galiti D, Karayianni A, Tsiklakis K, Psyrri A. Medication Related Osteonecrosis of the Jaw (MRONJ). Review and recent advances. Forum of Clinical Oncology [Internet]. 2022 Dec 1 [cited 2024 May 31];13(1):38–47. Available from: https://doi.org/10.2478/fco-2022-0005
Moreno-Rabié C, Lapauw L, Gaêta-Araujo H, Ferreira-Leite A, Coucke W, Van Den Wyngaert T, et al. Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction. Sci Rep [Internet]. 2022 Jul 4 [cited 2024 May 31];12(1):11280. Available from: https://doi.org/10.1038/s41598-022-15254-y
Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction - Moreno‐Rabié - 2024 - Oral Diseases - Wiley Online Library [Internet]. [cited 2024 May 31]. Available from: https://doi.org/10.1111/odi.14496
Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treatment Reviews [Internet]. 2018 Sep 1 [cited 2024 Jun 9];69:177–87. Available from: https://www.sciencedirect.com/science/article/pii/S0305737218301014
Mauceri R, Coniglio R, Abbinante A, Carcieri P, Tomassi D, Panzarella V, et al. The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists. Support Care Cancer [Internet]. 2022 Aug [cited 2024 May 31];30(8):6429–40. Available from: https://doi.org/10.1007/s00520-022-06940-8
Borromeo G, Tsao C, Darby I, Ebeling P. A review of the clinical implications of bisphosphonates in dentistry. Australian Dental Journal [Internet]. 2011 [cited 2024 May 31];56(1):2–9. Available from: https://doi.org/10.1111/j.1834-7819.2010.01283.x
Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, et al. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development? Journal of Cranio-Maxillofacial Surgery [Internet]. 2015 Jul 1 [cited 2024 Jun 9];43(6):847–54. Available from: https://doi.org/10.1016/j.jcms.2015.03.039
Ottesen C, Schiodt M, Gotfredsen K. Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review. Heliyon [Internet]. 2020 Apr 27 [cited 2024 Jun 11];6(4):e03795. Available from: https://doi.org/10.1016/j.heliyon.2020.e03795
Aboalela AA, Farook FF, Alqahtani AS, Almousa MA, Alanazi RT, Almohammadi DS. The Effect of Antiresorptive Drug Holidays on Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis. Cureus [Internet]. 2022 Oct 19 [cited 2024 May 31]; Available from: https://doi.org/10.7759/cureus.30485
Cartsos V, Koo S, Zavras A, Seamanduras A. Implications of bisphosphonate use
in dentistry. Analecta Peridontologica. [Internet] 2009 Jan 1 [cited 2024 Jun 5];20:1–15. Available from: https://www.researchgate.net/publication/262069933_Osteonecrosis_de_los_maxilares_por_bifosfonatos
Sadon A, Kukwa A, Sulik M. Medication-related osteonecrosis of the jaw – case report and current therapeutic recommendations. jstoma [Internet]. 2017 [cited 2024 Jun 9];70(1):95–108. Available from: https://doi.org/10.5604/01.3001.0010.1781
Okuyama K, Hayashida S, Rokutanda S, Kawakita A, Soutome S, Sawada S, et al. Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study. J Dent Sci [Internet]. 2021 Jul [cited 2024 Jun 9];16(3):885–90. Available from: https://doi.org/10.1016/j.jds.2020.12.007
Ramanauskaite A, Mangold K, Padhye N, Obreja K, Borschert F, Dahmer I, et al. Influence of antiresorptive/antiangiogenic therapy on changes in periodontal and oral tissue structures: a histomorphometrical analysis in rats. Clin Oral Invest [Internet]. 2023 Dec 1 [cited 2024 Jun 18];27(12):7695–704. Available from: https://doi.org/10.1007/s00784-023-05359-7
Moinzadeh AT, Shemesh H, Neirynck N a. M, Aubert C, Wesselink PR. Bisphosphonates and their clinical implications in endodontic therapy. International Endodontic Journal [Internet]. 2013 [cited 2024 May 31];46(5):391–8. Available from: https://doi.org/10.1111/iej.12018
Li JTW, Leung YY. Effect of Antiresorptive Drugs on Osseointegrated Dental Implants: A Systematic Review. Journal of Clinical Medicine [Internet]. 2024 Jan [cited 2024 May 31];13(7):2091. Available from: https://doi.org/10.3390/ jcm13072091
Papadakis I, Spanou A, Kalyvas D. Success Rate and Safety of Dental Implantology in Patients Treated With Antiresorptive Medication: A Systematic Review. Journal of Oral Implantology [Internet]. 2020 Jul 14 [cited 2024 May 31];47(2):169–80. Available from: https://doi.org/10.1563/aaid-joi-D-19-00088
Seki K, Namaki S, Kamimoto A, Hagiwara Y. Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review. Journal of Oral Implantology [Internet]. 2020 Dec 3 [cited 2024 Jun 29];47(6):502–10. Available from: https://doi.org/10.1563/aaid-joi-D-19-00385
Tanwir F, Mirza AA, Tauseef D, Mahar A. Bisphosphonates and the field of dentistry. European Journal of General Dentistry [Internet]. 2021 Nov 1 [cited 2024 Jun 29];3:11–6. Available from: https://doi.org/10.4103/2278-9626.126202
Marzec A, Minch L. Bisphosphonates and orthodontic treatment – a literature review. Forum Ortod [Internet]. 2020 [cited 2024 Jun 29];16(3):239–52. Available from: https://doi.org/10.5114/for.2020.100180
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aleksandra Dziewulska, Weronika Kiełt, Julia Kozłowska, Gabriela Broniec, Barbara Wajdowicz, Aleksandra Kudła, Rozalia Czapiewska, Aleksandra Wróbel, Laura Pacek, Klaudia Kowalska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 472
Number of citations: 0
